Literature DB >> 9822290

Scleroderma fibroblasts promote migration of mononuclear leucocytes across endothelial cell monolayers.

C P Denton1, X Shi-Wen, A Sutton, D J Abraham, C M Black, J D Pearson.   

Abstract

Perivascular infiltrates of inflammatory cells are a hallmark of lesional skin in scleroderma. We have explored the potential for scleroderma fibroblasts to modulate mononuclear leucocyte migration across endothelial cell monolayers in tissue culture, and to regulate expression of endothelial cell adhesion molecules. Fibroblasts were grown from skin biopsies of eight patients with active diffuse cutaneous scleroderma and from four healthy controls. Co-culture and conditioned medium transfer experiments examined the effect of soluble fibroblast products on mononuclear leucocyte (U937) cell migration across endothelial cell (1E-7) monolayers grown on tissue culture inserts. Co-culture of scleroderma, but not control fibroblasts, promoted transendothelial migration of U937 cells. Scleroderma fibroblast-conditioned medium had qualitatively similar effects and equivalent results were obtained using Jurkat-6 (T lymphocyte) cells, and with peripheral blood mononuclear cells from a patient with diffuse cutaneous scleroderma. Promotion of leucocyte migration does not appear to result from increased endothelial adhesion molecule expression, since fibroblast-conditioned medium did not up-regulate endothelial cell expression of intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) or E-selectin. Moreover, leucocyte migration across cytokine-activated endothelial cell layers in co-culture with fibroblasts was less than across resting cells, although the selective effect of scleroderma fibroblast co-culture persisted. Recombinant monocyte chemoattractant protein-1 (MCP-1) or IL-8 increased passage of mononuclear leucocytes across endothelial cell monolayers, whilst anti-MCP-1, but not anti-IL-8 antibodies, significantly reduced the effect of fibroblast conditioned medium. These data suggest that systemic sclerosis (SSc) fibroblasts promote leucocyte migration across endothelial cell monolayers in tissue culture via an MCP-1-dependent mechanism. These findings may be relevant to the perivascular mononuclear leucocyte infiltrates characteristic of early SSc lesions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9822290      PMCID: PMC1905096          DOI: 10.1046/j.1365-2249.1998.00721.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  37 in total

1.  Expression and function of surface antigens on scleroderma fibroblasts.

Authors:  D Abraham; S Lupoli; A McWhirter; C Plater-Zyberk; T H Piela; J H Korn; I Olsen; C Black
Journal:  Arthritis Rheum       Date:  1991-09

2.  Demonstration of interleukin 8 and autoantibodies to interleukin 8 in the serum of patients with systemic sclerosis and related disorders.

Authors:  S Reitamo; A Remitz; J Varga; M Ceska; F Effenberger; S Jimenez; J Uitto
Journal:  Arch Dermatol       Date:  1993-02

3.  Mechanisms of pathogenesis in scleroderma. I. Overproduction of interleukin 6 by fibroblasts cultured from affected skin sites of patients with scleroderma.

Authors:  C A Feghali; K L Bost; D W Boulware; L S Levy
Journal:  J Rheumatol       Date:  1992-08       Impact factor: 4.666

4.  Localization of collagen mRNA in normal and scleroderma skin by in-situ hybridization.

Authors:  K Scharffetter; B Lankat-Buttgereit; T Krieg
Journal:  Eur J Clin Invest       Date:  1988-02       Impact factor: 4.686

5.  Characterization of human umbilical vein endothelial cell lines produced by transfection with the early region of SV40.

Authors:  S A Fickling; J A Tooze; G S Whitley
Journal:  Exp Cell Res       Date:  1992-08       Impact factor: 3.905

6.  Persistence of scleroderma-like phenotype in normal fibroblasts after prolonged exposure to soluble mediators from mononuclear cells.

Authors:  J G Worrall; T L Whiteside; R K Prince; R B Buckingham; I Stachura; G P Rodnan
Journal:  Arthritis Rheum       Date:  1986-01

7.  Human leukemic models of myelomonocytic development: a review of the HL-60 and U937 cell lines.

Authors:  P Harris; P Ralph
Journal:  J Leukoc Biol       Date:  1985-04       Impact factor: 4.962

8.  Sequential dermal microvascular and perivascular changes in the development of scleroderma.

Authors:  R J Prescott; A J Freemont; C J Jones; J Hoyland; P Fielding
Journal:  J Pathol       Date:  1992-03       Impact factor: 7.996

9.  Paracrine induction of angiogenesis in vitro by Swiss 3T3 fibroblasts.

Authors:  R Montesano; M S Pepper; L Orci
Journal:  J Cell Sci       Date:  1993-08       Impact factor: 5.285

10.  The induction of 72-kD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent.

Authors:  A M Romanic; J A Madri
Journal:  J Cell Biol       Date:  1994-06       Impact factor: 10.539

View more
  19 in total

Review 1.  T lymphocyte and fibroblast interactions: the case of skin involvement in systemic sclerosis and other examples.

Authors:  C Chizzolini
Journal:  Springer Semin Immunopathol       Date:  1999

2.  Hypoxia induces expression of the chemokines monocyte chemoattractant protein-1 (MCP-1) and IL-8 in human dermal fibroblasts.

Authors:  M Galindo; B Santiago; J Alcami; M Rivero; J Martín-Serrano; J L Pablos
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

3.  Differing distributions of CXCR3- and CCR4-positive cells among types of interstitial pneumonia associated with collagen vascular diseases.

Authors:  Shigeki Shimizu; Takeo Yoshinouchi; Takashi Niimi; Yuji Ohtsuki; Jiro Fujita; Hiroyoshi Maeda; Shigeki Sato; Ichiro Yamadori; Tadaaki Eimoto; Ryuzo Ueda
Journal:  Virchows Arch       Date:  2006-11-24       Impact factor: 4.064

4.  Increased transendothelial migration of scleroderma lymphocytes.

Authors:  G H Stummvoll; M Aringer; J Grisar; C W Steiner; J S Smolen; R Knobler; W B Graninger
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

5.  Increased expression of S100A8 and S100A9 in patients with diffuse cutaneous systemic sclerosis. A correlation with organ involvement and immunological abnormalities.

Authors:  Xue Xu; Wen-Yu Wu; Wen-Zheng Tu; Hai-Yan Chu; Xiao-Xia Zhu; Min-Rui Liang; Yu Xue; Jiu-Cun Wang; He-Jian Zou
Journal:  Clin Rheumatol       Date:  2013-06-11       Impact factor: 2.980

Review 6.  Vascular disease in scleroderma.

Authors:  Fredrick M Wigley
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

Review 7.  Adverse fibrosis in the aging heart depends on signaling between myeloid and mesenchymal cells; role of inflammatory fibroblasts.

Authors:  Katarzyna A Cieslik; JoAnn Trial; Jeffrey R Crawford; George E Taffet; Mark L Entman
Journal:  J Mol Cell Cardiol       Date:  2013-10-31       Impact factor: 5.000

8.  Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement.

Authors:  E Scala; S Pallotta; A Frezzolini; D Abeni; C Barbieri; F Sampogna; O De Pità; P Puddu; R Paganelli; G Russo
Journal:  Clin Exp Immunol       Date:  2004-12       Impact factor: 4.330

9.  Transforming growth factor β1 (TGFβ1)-induced CD44V6-NOX4 signaling in pathogenesis of idiopathic pulmonary fibrosis.

Authors:  Shibnath Ghatak; Vincent C Hascall; Roger R Markwald; Carol Feghali-Bostwick; Carol M Artlett; Monika Gooz; Galina S Bogatkevich; Ilia Atanelishvili; Richard M Silver; Jeanette Wood; Victor J Thannickal; Suniti Misra
Journal:  J Biol Chem       Date:  2017-04-07       Impact factor: 5.486

10.  Fibroblasts from different sites may promote or inhibit recruitment of flowing lymphocytes by endothelial cells.

Authors:  Helen M McGettrick; Emily Smith; Andrew Filer; Stephen Kissane; Michael Salmon; Christopher D Buckley; G Ed Rainger; Gerard B Nash
Journal:  Eur J Immunol       Date:  2009-01       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.